Together with the currently available resources, these datasets allow for the understanding of molecular mechanisms of the effect of TET2 mutations on the risk of thrombosis and open the prospect of the discovery of new targets and biomarkers for VTE (75). This evidence concerns the gene TET2 and Venous thrombosis.